Colorado 2018 Regular Session Status: Died 1 D cosponsors

HB 18-1260 — Prescription Drug Price Transparency

Last action — Senate Committee on State, Veterans, & Military Affairs Postpone Indefinitely

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. Died in session

This bill died with 2018 Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

The bill enacts the 'Colorado Prescription Drug Price Transparency Act of 2018', which requires: Health insurers, starting in 2021, to submit to the commissioner of insurance (commissioner), as part of the health care cost reporting requirement, information regarding prescription drugs covered under their health insurance plans that were dispensed in the preceding calendar year; Prescription drug manufacturers to notify state purchasers, health insurers, and pharmacy benefit management firms when the manufacturer, on or after July 1, 2020, increases the price of certain prescription drugs by more than 10% or introduces a new specialty drug in the commercial market; and Prescription drug manufacturers, within 15 days after the end of each calendar quarter that starts on or after July 1, 2020, to provide specified information to the commissioner regarding the drugs about which manufacturers are required to notify purchasers of a drug price increase or new specialty drug on the market. The commissioner is required to post the information received from prescription drug manufacturers on the division of insurance website. Additionally, the commissioner, or a disinterested third-party contractor, is to analyze the data submitted by health insurers and prescription drug manufacturers and other relevant information to determine the effect of prescription drug costs on health insurance premiums. The commissioner is to publish a report each year, submit the report to specified legislative committees, and present the report during annual 'State Measurement for Accountable, Responsive, and Transparent (SMART) Government Act' hearings. The commissioner is authorized to adopt rules as necessary to implement the requirements of the act. A prescription drug manufacturer that fails to notify purchasers or fails to report required data to the commissioner is subject to discipline by the state board of pharmacy, including a penalty of $1,000 per day for each day the manufacturer fails to comply with the notice or reporting requirements. The commissioner is to report manufacturer violations to the state board of pharmacy. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) Read More

Bill Text

What changed in the latest version

17 added · 20 removed

Plain-language change summary

In the most recent version of Bill HB 18-1260, references to specific insurance plans that were dispensed in the previous calendar year have been clearly included and clarified. This change helps ensure that the bill addresses the relevant time frame for those insurance plans, which is important for accurate record-keeping and compliance. These updates make it easier for stakeholders to understand the requirements, ultimately improving the bill's effectiveness in delivering its intended benefits.

→
Previous
Latest
Second Regular Session Seventy-first General Assembly STATE OF COLORADO REENGROSSED This Version Includes All Amendments Adopted in the House of Introduction LLS NO.
Second Regular Session Seventy-first General Assembly STATE OF COLORADO ENGROSSED This Version Includes All Amendments Adopted on Second Reading in the House of Introduction LLS NO.
This summary applies to this bill as introduced and does notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill passes third reading in the house of introduction, a bill summary that e applies to the reengrossed version of this bill will be available at n m 1 http://leg.colorado.gov.) E n 2 U U 7 The bill enacts the "Colorado Prescription Drug Price O i i H a p Transparency Act of 2018", which requires:
This summary applies to this bill as introduced and does notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill passes third reading in the house of introduction, a bill summary that applies to the reengrossed version of this bill will be available at http://leg.colorado.gov.) The bill enacts the "Colorado Prescription Drug Price Transparency Act of 2018", which requires:
R A ! Health insurers, starting in 2019, to submit to the r commissioner of insurance (commissioner), as part of the health care cost reporting requirement, information regarding prescription drugs covered under their health i insurance plans that were dispensed in the preceding a 1 calendar year;
! Health insurers, starting in 2019, to submit to the commissioner of insurance (commissioner), as part of the health care cost reporting requirement, information regarding prescription drugs covered under their health i 8 insurance plans that were dispensed in the preceding a 0 calendar year;
E e 2 U d 2 O 2 i Shading denotes HOUSE amendment.
S R , O n 1 Shading denotes HOUSE amendment.
H d p Capital letters or bold & italic numbers indicate new material to be added to existing statude.
H 2 r Capital letters or bold & italic numbers indicate new material to be added to existing dtatute.
e A ! Prescription drug manufacturers, on or after July 1, 2018, to notify state purchasers, health insurers, and pharmacy benefitmanagementfirmswhenthemanufacturerincreases thepriceofcertainprescriptiondrugsbymorethan10%or when the manufacturer introduces a new specialty drug in the commercial market;
e m A ! Prescription drug manufacturers, on or after July 1, 2018, to notify state purchasers, health insurers, and pharmacy benefitmanagementfirmswhenthemanufacturerincreases thepriceofcertainprescriptiondrugsbymorethan10%or when the manufacturer introduces a new specialty drug in the commercial market;
⬇ Download PDF
View plain text versions (4)

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Senate Committee on State, Veterans, & Military Affairs Postpone Indefinitely

  2. House Third Reading Passed - No Amendments

  3. Introduced In Senate - Assigned to State, Veterans, & Military Affairs

  4. House Third Reading Laid Over to 04/17/2018 - No Amendments

  5. House Third Reading Laid Over Daily - No Amendments

  6. House Second Reading Special Order - Passed with Amendments - Committee

  7. House Second Reading Laid Over Daily - No Amendments

  8. House Second Reading Laid Over to 04/11/2018 - No Amendments

  9. House Second Reading Laid Over to 04/10/2018 - No Amendments

  10. House Second Reading Laid Over to 04/09/2018 - No Amendments

  11. House Second Reading Laid Over to 04/04/2018 - No Amendments

  12. House Second Reading Laid Over to 04/03/2018 - No Amendments

  13. House Second Reading Laid Over to 04/02/2018 - No Amendments

  14. House Committee on Appropriations Refer Unamended to House Committee of the Whole

  15. House Committee on Health, Insurance, & Environment Refer Amended to Appropriations

  16. Introduced In House - Assigned to Health, Insurance, & Environment

Sponsors

  • Joann Ginal · Primary
  • Dominick Moreno · Primary
  • Jamie Jackson · Primary

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 0 co-sponsors · 99 not signed on · 5 voted No

Sponsors (3)

Co-sponsors (0)

None.

Not signed on (99)

99 members have not signed on to this bill.

Show all 99 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

BILL

Passed 33 Yea · 30 Nay · 2 Other
Party YeaNayPresentNot Voting
Unaffiliated 242800
Democrat 8001
Republican 1201
Total 333002
% of votes cast 51%46%0%3%
How each member voted (65)
Member Party Vote
Becker J. — Nay
Becker K. — Yea
Buckner — Yea
McLachlan — Yea
Neville P. — Nay
Salazar — Yea
Young — Yea
Arndt — Nay
Beckman — Nay
Buck — Nay
Carver — Nay
Covarrubias — Nay
Esgar — Yea
Everett — Nay
Foote — Yea
Garnett — Yea
Ginal — Yea
Gray — Yea
Hamner — Yea
Hansen — Yea
Herod — Yea
Hooton — Yea
Humphrey — Nay
Kraft-Tharp — Yea
Landgraf — Nay
Lawrence — Nay
Lee — Yea
Leonard — Nay
Lontine — Yea
Lundeen — Nay
McKean — Nay
Melton — Yea
Pabon — Nay
Pettersen — Yea
Rankin — Nay
Ransom — Nay
Reyher — Nay
Rosenthal — Yea
Saine — Nay
Sandridge — Nay
Sias — Nay
Singer — Yea
Thurlow — Nay
Willett — Nay
Winkler — Nay
Wist — Nay
Adrienne Benavidez — Yea
Jaquez Lewis — Nay
Michaelson Jenet — Yea
Van Winkle — Nay
Williams D. — Nay
deGruy Kennedy — Yea
Alex Valdez Democrat Yea
Dylan Roberts Democrat Yea
James Coleman Democrat Yea
Jamie Jackson Democrat Yea
Jeff Bridges Democrat Not Voting
Jessie Danielson Democrat Yea
Mike Weissman Democrat Yea
Monica Duran Democrat Yea
Tony Exum Democrat Yea
Larry Liston Republican Nay
Lynda Zamora Wilson Republican Nay
Marc Catlin Republican Not Voting
Ty Winter Republican Yea

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 18-1260 do?
The bill enacts the 'Colorado Prescription Drug Price Transparency Act of 2018', which requires: Health insurers, starting in 2021, to submit to the commissioner of insurance (commissioner), as part of the health care cost reporting requirement, information regarding prescription drugs covered under their health insurance plans that were dispensed in the preceding calendar year; Prescription drug manufacturers to notify state purchasers, health insurers, and pharmacy benefit management firms when the manufacturer, on or after July 1, 2020, increases the price of certain prescription drugs by more than 10% or introduces a new specialty drug in the commercial market; and Prescription drug manufacturers, within 15 days after the end of each calendar quarter that starts on or after July 1, 2020, to provide specified information to the commissioner regarding the drugs about which manufacturers are required to notify purchasers of a drug price increase or new specialty drug on the market. The commissioner is required to post the information received from prescription drug manufacturers on the division of insurance website. Additionally, the commissioner, or a disinterested third-party contractor, is to analyze the data submitted by health insurers and prescription drug manufacturers and other relevant information to determine the effect of prescription drug costs on health insurance premiums. The commissioner is to publish a report each year, submit the report to specified legislative committees, and present the report during annual 'State Measurement for Accountable, Responsive, and Transparent (SMART) Government Act' hearings. The commissioner is authorized to adopt rules as necessary to implement the requirements of the act. A prescription drug manufacturer that fails to notify purchasers or fails to report required data to the commissioner is subject to discipline by the state board of pharmacy, including a penalty of $1,000 per day for each day the manufacturer fails to comply with the notice or reporting requirements. The commissioner is to report manufacturer violations to the state board of pharmacy. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) Read More
Who sponsors HB 18-1260?
HB 18-1260 is sponsored by Joann Ginal, Dominick Moreno, and Jamie Jackson (Democrat).
What is the current status of HB 18-1260?
This bill died with 2018 Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 18-1260?
Track HB 18-1260 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 18-1260

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 18-1260

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →